Patents
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
12/2010
12/22/2010CN101433588B Method for producing five-ester dropping pills
12/22/2010CN101416958B Use of 15-methano-substituted-andrographolide derivative in preparing anti-hepatitis B medicine
12/22/2010CN101411808B Method for preparing Chinese medicine for treating heat intestine and stomach type constipation
12/22/2010CN101401900B Chinese medicinal composition for treating gastric, duodenal ulcer
12/22/2010CN101391088B Enterogastritis oral medicine
12/22/2010CN101371925B Nano silver-cell growth factor sustained-release composite body as well as preparation method and use thereof
12/22/2010CN101284041B Compound radix astragali Chinese medicinal formulations with health-care function
12/22/2010CN101279072B Chinese medicine capsule for curing digestive system disease
12/22/2010CN101264051B Modified release pharmaceutical formulation
12/22/2010CN101239058B Proanhocyanidins compounds for preparing medicaments and health care food for preventing and controlling helicobacter pylori associated gastritis
12/22/2010CN101239037B Acetylcysteine injection and preparation thereof
12/22/2010CN101209342B Application of helianthus tuberosus agglutinin in preparing medicine for treating constipation and delaying stomach and intestine retrogradation
12/22/2010CN101208330B Method of preparing esomeprazole and salts thereof
12/22/2010CN101181373B Cortex moutan valid target pharmaceutical combination, preparation method and application thereof
12/22/2010CN101128436B Glycine derivative and use thereof
12/22/2010CN101103755B Method for producing convenient nutritive rice-tea and product
12/22/2010CN101095951B Therapeutic HBV DNA vaccines, method for preparing the same and application thereof
12/22/2010CN101040650B Health-care type ganoderma lucidum combined tea
12/21/2010US7855288 For treatment of cytokine-associated conditions
12/21/2010US7855230 FDA Orange book listed patent for fesoterodine fumarate; urinary incontinence; isobutyric acid 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethylphenyl ester is fesoteridine
12/21/2010US7855219 2-Amino-4-(1,3-benzodioxol-5-yl)-6-benzyloxy-3,5-pyridinedicarbonitrile, acting as adenosine-receptor-selective ligands, for the prophylaxis and/or treatment of cardiovascular disorders
12/21/2010US7855202 useful in the treatment respiratory system disorders, allergic diseases, inflammation, reperfusion injury, ischemia, atherosclerosis, hypertension, retinopathy, diabetes, gastrointestinal disorders and/or autoimmune diseases
12/21/2010US7855198 Benzamide derivative or salt thereof
12/21/2010US7855184 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells and methods of treating ophthalmic and dermatological diseases
12/21/2010US7854942 Anti-gluten egg yolk antibodies for the treatment of celiac disease
12/21/2010US7854933 Compositions and methods for identifying and targeting cancer cells of alimentary canal origin
12/21/2010CA2609494C Motilide compounds
12/21/2010CA2569654C Benzimidazolone carboxylic acid derivatives
12/21/2010CA2492718C Prodrugs of proton pump inhibitors
12/21/2010CA2483345C Imidazolinylmethyl aralkylsulfonamides
12/21/2010CA2470109C Substituted phenyl naphthalenes as estrogenic agents
12/21/2010CA2453823C Dermal therapy using phosphate derivatives of electron transfer agents
12/21/2010CA2434337C Combination of probiotics
12/21/2010CA2426654C 2,4,8-trisubstituted-8h-pyrido[2,3-d}pyrimidin-7-one compounds
12/21/2010CA2412004C Glucagon-like peptide-1 analogs
12/21/2010CA2378396C Composition containing extracts of butyrospermum parkii and the use as medicament or dietary supplement
12/21/2010CA2371517C An improving agent for hypoalbuminaemia
12/16/2010WO2010144865A2 Methods for treating gastrointestinal disorders
12/16/2010WO2010144502A2 Growth hormone polypeptides and methods of making and using same
12/16/2010WO2010144498A2 Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate
12/16/2010WO2010144446A1 (s) -2-benzyl-3- ( (3r, 4r) -4- (3 -carbamo ylphenyl) -3, 4-dimethylpiperidinyl) propanoic acid and salt therof as antagonists of the opioid receptors
12/16/2010WO2010144140A2 Egfr and par2 regulation of intestinal permeability
12/16/2010WO2010144055A1 Novel compounds and uses thereof
12/16/2010WO2010144044A1 Use of a composition for the treatment of mucositis
12/16/2010WO2010143101A1 Use of 1,25-dihydroxyvitamine d3 glycoside in lactating animals.
12/16/2010WO2010142997A1 Use of a serum composition to reduce the levels of tnf and/or vegf in mammals
12/16/2010WO2009144555A8 Pyrazolospiroketone acetyl-coa carboxylase inhibitors
12/16/2010US20100319073 GDE Compositions and Methods
12/16/2010US20100317854 Novel aminodicarboxylic acid derivatives having pharmaceutical properties
12/16/2010US20100317720 Methods and Compositions for the Treatment of Intestinal Conditions
12/16/2010US20100317719 Antisense Oligonucleotides (ODN) Against SMAD7 and Uses Thereof in Medical Field
12/16/2010US20100317689 Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
12/16/2010US20100317664 Methods of affecting gastrointestinal transit and gastric emptying, and compounds useful therein
12/16/2010US20100317661 Small molecule inhibitors of mdm2 and the uses thereof
12/16/2010US20100317654 1,4-diaza-bicyclo[3.2.2]nonyl oxadiazolyl derivatives and their medical use
12/16/2010US20100317650 Imidazopyridine derivatives useful as inos inhibitors
12/16/2010US20100317649 S1P Receptor Modulating Compounds and Use Thereof
12/16/2010US20100317643 Janus kinase inhibitor compounds and methods
12/16/2010US20100317626 The Use Of (3-Amino-2-Fluoropropyl) Phosphinic Acid For Treatment Of NERD
12/16/2010US20100317572 Pharmaceutical composition comprising tesofensine or its analogue and an anti-obesity compound
12/16/2010US20100316727 Treatment of inflammatory disorders with ozone
12/16/2010US20100316709 Orally disintegrating solid preparation
12/16/2010US20100316706 Carbocyclic and oxacarbocyclic fumaric acid oligomers
12/16/2010US20100316627 Human antibodies to human IL-6 receptor
12/16/2010US20100316624 Treatment of fibroses and liver disorders
12/16/2010US20100316617 Use of hydrogenotrophic acetogenic strains for preventing or treating digestive disorders
12/16/2010US20100316611 Self-containing lactococcus strain
12/16/2010US20100316596 Compositions and methods for treatment of diseases and disorders associated with cytokine signaling
12/16/2010CA2765075A1 Egfr and par2 regulation of intestinal permeability
12/16/2010CA2765033A1 Methods for treating gastrointestinal disorders
12/16/2010CA2764981A1 (s) -2-benzyl-3- ( (3r, 4r) -4- (3 -carbamoylphenyl) -3, 4-dimethylpiperidinyl) propanoic acid and salt therof as antagonists of the opioid receptors
12/16/2010CA2764587A1 Treatment of portal hypertension and restoration of liver function using l-ornithine phenylacetate
12/16/2010CA2764105A1 Growth hormone polypeptides and methods of making and using same
12/16/2010CA2763092A1 Use of a composition for the treatment of mucositis
12/15/2010EP2261216A2 Pyrazoles as glucokinase activators
12/15/2010EP2261210A1 3-substituted sulfonyl piperazine derivative
12/15/2010EP2261206A1 Indolinone compound
12/15/2010EP2261200A2 Modified forms of pharmacacologically active agents and uses therefor
12/15/2010EP2260872A2 Polymer conjugates of interferon beta-1A and uses thereof
12/15/2010EP2260867A1 TWEAK receptor agonists as anti-angiogenic agents
12/15/2010EP2260843A2 Alpha-MSH and derivatives for the induction of tolerance against antigens
12/15/2010EP2260837A1 Pharmaceutical compositions for the coordinated delivery of NSAIDs
12/15/2010EP2260832A2 Optimal polymer mixtures for gastric retentive tablets
12/15/2010EP2260101A1 Microrna (mirna) and downstream targets for diagnostic and therapeutic purposes
12/15/2010EP2259789A2 Pharmaceutical kit consisting of an oil-in-water emulsion and a solid composition
12/15/2010EP2048145B1 Protein kinase c activity enhancer containing alkyl ether derivative or salt thereof
12/15/2010EP1807084B1 Use of pyrrolopyrazine derivatives for the production of medicaments for the treatment of mucoviscidosis
12/15/2010EP1444523B1 Screening for hepatitis c virus entry inhibitors
12/15/2010EP1423380B1 Pyrazole-derived kinase inhibitors and uses thereof
12/15/2010EP1053001B1 Novel mixed amylin activity compounds
12/15/2010CN1969924B Pharmaceutical composition of Silibinin and isatis root
12/15/2010CN1872166B Drop pills of magnolia vine fruit kernel and preparation method
12/15/2010CN1857489B Preparing process of hemp seed soft capsule for treating constipation
12/15/2010CN1857334B Glossy ganoderma spore oil emulsion for intravenous injection and its preparing method
12/15/2010CN1708480B Carotenoid analogs for the inhibition and amelioration of disease
12/15/2010CN1547475B Dermal therapy using phosphate derivatives of electron transfer agents
12/15/2010CN101918391A Some 2-pyrazinone derivatives and their use as inhibitors of neutrophile elastase
12/15/2010CN101918017A Use of PHY906 as treatment for inflammatory bowel disease and/or irritable bowel syndrome
12/15/2010CN101918014A Medicinal composition
12/15/2010CN101918013A Use of lactobacillus casei for increasing the protection provided by the influenza vaccine